메뉴 건너뛰기




Volumn 115, Issue 3, 2009, Pages 339-342

Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma

Author keywords

Health disparities; Neo adjuvant chemotherapy; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; MELPHALAN;

EID: 70350571175     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.08.008     Document Type: Article
Times cited : (8)

References (21)
  • 1
    • 84866763346 scopus 로고    scopus 로고
    • Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    • Morrison J., Swanton A., Collins S., et al. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst. Rev. 4 (2007) CD005343
    • (2007) Cochrane Database Syst. Rev. , Issue.4
    • Morrison, J.1    Swanton, A.2    Collins, S.3
  • 2
    • 67650225751 scopus 로고    scopus 로고
    • Carcinoma of the ovary. 26th Annual report on the results of treatment in gynecological cancer
    • Pecorelli S. Carcinoma of the ovary. 26th Annual report on the results of treatment in gynecological cancer. Int. J. Gynaecol. Obstet. 95 10 (2006) S171
    • (2006) Int. J. Gynaecol. Obstet. , vol.95 , Issue.10
    • Pecorelli, S.1
  • 3
    • 63049115790 scopus 로고    scopus 로고
    • Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the gynecologic cancer intergroup
    • Bookman M.A., Brady M.F., McGuire W.P., et al. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the gynecologic cancer intergroup. J. Clin. Oncol. 27 9 (2009) 1419-1425
    • (2009) J. Clin. Oncol. , vol.27 , Issue.9 , pp. 1419-1425
    • Bookman, M.A.1    Brady, M.F.2    McGuire, W.P.3
  • 4
    • 0025314435 scopus 로고
    • Neoadjuvant chemotherapy in stage X ovarian carcinoma
    • Chambers J.T., Chambers S.K., Voynick I.M., et al. Neoadjuvant chemotherapy in stage X ovarian carcinoma. Gynecol. Oncol. 37 3 (1990) 327-331
    • (1990) Gynecol. Oncol. , vol.37 , Issue.3 , pp. 327-331
    • Chambers, J.T.1    Chambers, S.K.2    Voynick, I.M.3
  • 5
    • 0028231205 scopus 로고
    • Neoadjuvant chemotherapy for advanced ovarian cancer
    • Schwartz P.E., Chambers J.T., and Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol. Oncol. 53 1 (1994) 33-37
    • (1994) Gynecol. Oncol. , vol.53 , Issue.1 , pp. 33-37
    • Schwartz, P.E.1    Chambers, J.T.2    Makuch, R.3
  • 6
    • 0032926077 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival
    • Schwartz P.E., Rutherford T.J., Chambers J.T., et al. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol. Oncol. 72 1 (1999) 93-99
    • (1999) Gynecol. Oncol. , vol.72 , Issue.1 , pp. 93-99
    • Schwartz, P.E.1    Rutherford, T.J.2    Chambers, J.T.3
  • 7
    • 45349096041 scopus 로고    scopus 로고
    • American Cancer Society, American Cancer Society, Atlanta, Ga
    • American Cancer Society. Cancer Facts and Figures 2008 (2008), American Cancer Society, Atlanta, Ga
    • (2008) Cancer Facts and Figures 2008
  • 8
    • 40749132975 scopus 로고    scopus 로고
    • Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis
    • Halpern M.T., Ward E.M., Pavluck A.L., et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 9 3 (2008) 222-231
    • (2008) Lancet Oncol. , vol.9 , Issue.3 , pp. 222-231
    • Halpern, M.T.1    Ward, E.M.2    Pavluck, A.L.3
  • 9
    • 34248374708 scopus 로고    scopus 로고
    • Predictors of comprehensive surgical treatment in patients with ovarian cancer
    • Goff B.A., Matthews B.J., Larson E.H., et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 109 10 (2007) 2031-2042
    • (2007) Cancer , vol.109 , Issue.10 , pp. 2031-2042
    • Goff, B.A.1    Matthews, B.J.2    Larson, E.H.3
  • 10
  • 11
    • 36048952659 scopus 로고    scopus 로고
    • Operative management of primary epithelial ovarian cancer
    • Leitao M.M., and Chi D.S. Operative management of primary epithelial ovarian cancer. Curr. Oncol. Rep. 9 6 (2007) 478-484
    • (2007) Curr. Oncol. Rep. , vol.9 , Issue.6 , pp. 478-484
    • Leitao, M.M.1    Chi, D.S.2
  • 12
    • 41749092567 scopus 로고    scopus 로고
    • Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005)
    • Chen A.Y., Halpern M.T., Schrag N.M., et al. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). J. Natl. Cancer Inst. 100 7 (2008) 462-474
    • (2008) J. Natl. Cancer Inst. , vol.100 , Issue.7 , pp. 462-474
    • Chen, A.Y.1    Halpern, M.T.2    Schrag, N.M.3
  • 13
    • 33947322200 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease
    • Hou J.Y., Kelly M.G., Yu H., et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol. Oncol. 105 1 (2007) 211-217
    • (2007) Gynecol. Oncol. , vol.105 , Issue.1 , pp. 211-217
    • Hou, J.Y.1    Kelly, M.G.2    Yu, H.3
  • 14
    • 33750905940 scopus 로고    scopus 로고
    • Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
    • Bristow R.E., and Chi D.S. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol. Oncol. 103 3 (2006) 1070-1076
    • (2006) Gynecol. Oncol. , vol.103 , Issue.3 , pp. 1070-1076
    • Bristow, R.E.1    Chi, D.S.2
  • 15
    • 33846367782 scopus 로고    scopus 로고
    • Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction
    • Bristow R.E., Eisenhauer E.L., Santillan A., et al. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol. Oncol. 104 2 (2007) 480-490
    • (2007) Gynecol. Oncol. , vol.104 , Issue.2 , pp. 480-490
    • Bristow, R.E.1    Eisenhauer, E.L.2    Santillan, A.3
  • 16
    • 8844266000 scopus 로고    scopus 로고
    • Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma
    • Liu E.L., and Mi R.R. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma. Chin. Med. J. (Engl) 117 10 (2004) 1547-1551
    • (2004) Chin. Med. J. (Engl) , vol.117 , Issue.10 , pp. 1547-1551
    • Liu, E.L.1    Mi, R.R.2
  • 17
    • 70350575324 scopus 로고    scopus 로고
    • 12th IGCS biennial meeting
    • Griffen T. 12th IGCS biennial meeting. Lancet Oncol. 9 12 (2008) 1129
    • (2008) Lancet Oncol. , vol.9 , Issue.12 , pp. 1129
    • Griffen, T.1
  • 18
    • 70350569359 scopus 로고    scopus 로고
    • Cancer Facts and Figures for Hispanics/Latinos 2006-2008. American Cancer Society, Atlanta, Georgia.
    • Cancer Facts and Figures for Hispanics/Latinos 2006-2008. American Cancer Society, Atlanta, Georgia.
  • 19
    • 70350571788 scopus 로고    scopus 로고
    • Cancer Facts and Figures for African Americans 2006-2008. American Cancer Society, Atlanta, Georgia.
    • Cancer Facts and Figures for African Americans 2006-2008. American Cancer Society, Atlanta, Georgia.
  • 20
    • 70350567226 scopus 로고    scopus 로고
    • www.cancer.gov


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.